Meda Biotech LLc. is a USA based company focused on product development using its patented technology. Meda has infused the modern science with ancient discoveries for its supplements. Our main focus is to improve an existing or new drug to make a better product. Our company is working on a straight-forward technology aimed at reducing dosage (frequency and total amount) requirements and side effects. To accomplish this type of technology, we are hybridizing the drug to achieve (increase) water solubility; this also increases the effects of the drug. Existing techiques use multiple expensive steps and almost everyone use just polymers or proteins to make drugs more soluble. Meda's hybrid formulation technology is simple and cost effective to achieve required solubility. Meda uses a partner molecule for solubility, which also provides synergistic and potentiating effects to parent drug, without changing the basic chemistry of active molecules.
We are currently working on furthering a water-soluble version of Taxol that is garnering substantial interest. We are so confident in our technology and its cost manufacturing effeciency, that we are willing to discuss a proof-of-concept proposal from your product portfolio we will work with you to select a candidate to adapt into a new, water-soluble form that can be evaluated for various characteristics. If you want to become a part of our mission of development and production of novel treatment, prevention and healthy style, please do contacts us at email@example.com, firstname.lastname@example.org, or email@example.com. For more information about our company, please be free to look at our pamphlet.
We stand behind the performance of our product and give you a piece of mind with money back guarantee.
Nanomedicine Supplements Diagnosis
*Our Meda brand products are produced in USA. All raw materials used in our products and all batches of finished products are laboratory tested prior to release.
**If any of our American fellows cannot afford to purchase our products please send us an email and we will send you free of cost.
We have discovered a new generation of hybrid technology to develop Hybrid Drugs. Products in pipeline;
* Mewtaxol (Paclitaxel Hybrid)
* Ascurin (Aspirin Hybrid)
* Coxcur (Arthritis)
* Conjugated Lectin drug delivery system
* Preventive Life Style Drugs
* GERD (Acid Reflux)
Funds are needed for clinical trials for patented products
A. Hybrid drugs
B. Oral Vaccine
C. ADC ( recombinant antibodies)
Copyright 2013 Meda Biotech LLc. All rights reserved.